Shares of Becton Dickinson & Co. BDX rose 1.22% to $202.32 Wednesday, on what proved to be an all-around favorable trading ...

The stock's rise snapped a four-day losing streak.

From El Paso, Texas, to Richmond, Virginia, medical device warehouses are leaking ethylene oxide, a cancer-causing chemical.

Piper Sandler analyst Jason Bednar lowered the firm’s price target on Becton Dickinson to $260 from $280 and keeps an Overweight rating on the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Becton Dickinson (BDX – Research Report), ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance ...

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

BDX's AI-based advanced hemodynamic monitoring platform is likely to aid clinicians to address blood flow instability and pressure in critical situations and improve patient outcomes.

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that ...

Becton, Dickinson and Company had a return on equity of 15.74% and a net margin of 8.47%. On average, research analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the ...

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory ...